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Trypanosoma cruzi, the causative agent of Chagas’ disease, which aﬀects a large number of individuals in Central and South
America, is transmitted to vertebrate hosts by blood-sucking insects. This protozoan is an obligate intracellular parasite. The
infective forms of the parasite are metacyclic and bloodstream trypomastigote and amastigote. Metacyclic trypomastigotes are
released with the feces of the insect while amastigotes and bloodstream trypomastigotes are released from the infected host cells
of the vertebrate host after a complex intracellular life cycle. The recognition between parasite and mammalian host cell involves
numerous molecules present in both cell types. Here, we present a brief review of the interaction between Trypanosoma cruzi and
itshostcells,mainlyemphasizingthemechanismsandmoleculesthatparticipateintheT.cruziinvasionprocessofthemammalian
cells.
1.IntroductiontoT. cruzi and Its Life Cycle
Protozoa of the Trypanosomatidae family are agents of
parasitic diseases that have a high incidence and a negative
economic impact in developing countries. In the case of
leishmaniasis, caused by several species of Leishmania,a b o u t
sixteen million people are infected in Africa, Asia, parts of
Europe, and Latin America. Sleeping sickness, caused by
the Trypanosoma brucei group, aﬀects about three million
people in Africa. In the case of Chagas’ disease, caused by
Trypanosoma cruzi, sixteen to eighteen million individuals
are infected and more than 80 million are at risk of infection
(http://www.who.org/). Some trypanosome species are also
important in veterinary medicine, since they have been
seriously aﬀecting animals of economic interest such as
horses and cattle. Diseases caused by plant trypanosomatids
are increasing in importance owing to the serious problems
they have caused in coconut and oil palm plantations in
South America.
One speciﬁc feature of the trypanosomatids is that
they change their general shape during their life cycle. In
those species that switch from vertebrate to invertebrate
hosts, this and other changes may be dramatic, involving
the appearance of developmental stages which do not
divide and stages which are highly infective through a
process generally described as protozoan diﬀerentiation or
transformation [1, 2]. Among the trypanosomatids, T. cruzi
presents one of the most complex life cycles involving
several developmental stages found in the vertebrate and
the invertebrate hosts as well as in the bloodstream and
within vertebrate host cells. Figure 1 shows a general view
of the life cycle of this protozoan. Let us consider that
the cycle starts with insects from the Reduviidae family
sucking the blood of vertebrates infected with the trypo-
mastigote forms which circulate in the bloodstream (known
as bloodstream trypomastigotes). Once ingested, most of
the trypomastigotes are lysed in the insect’s stomach [3].
The surviving trypomastigotes transform, in a few days2 International Journal of Cell Biology
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Figure 1:LifecycleofT.cruzishowingthevariousformsoftheprotozoanintheinvertebrate(triatomines)andvertebrate(mammals)hosts.
Figure reproduced from the Center of Control Diseases homepage.
later, either into spherical stage (known as spheromastigotes)
or into epimastigote stage. Epimastigotes migrate to the
intestine where they divide intensely and attach to the
perimicrovillar membranes which are secreted by intestinal
cells of posterior midgut [4, 5]. This adhesion step seems
to be important to trigger the process of transformation
of the noninfective epimastigotes into highly infective try-
pomastigotes (known as metacyclic trypomastigotes). The
adhesion process of epimastigotes to the perimicrovillar
membranes involves the participation of surface-exposed
glycoconjugates. Several proteins found in the perimicrovil-
lar membranes seem to be involved in this process [4].
Also, surface glycoinositolphospholipids (GIPLs) of the
parasite have been shown to be involved in the attachment
process [5]. Several saccharides are able to inhibit parasite
attachment.
At the most posterior regions of the intestine and at
the rectum, many epimastigotes detach from the intesti-
nal surface and transform into metacyclic trypomastigote
forms which are then released together with feces and
urine [6]. These stages are also designated as metacyclic
trypomastigotes which are highly infective for several mam-
malian species, including human. Usually the infection of
mammalian takes place through direct inoculation of these
forms through the ocular mucosa or the lesioned skin
during insect blood meal. Other important transmission
mechanisms are by blood transfusion, transplacentary, and
organ transplant. Nowadays these mechanisms are much
less frequent due to vector control programs and careful
analysis of blood donors. However, it has been shown quite
recently that these stages are also infective through the
oral route [7]. Once in the vertebrate host, the metacyclicInternational Journal of Cell Biology 3
trypomastigotes invade the cells at the inoculation site
(e.g., ﬁbroblasts, macrophages, and epithelial cells) through
recognizing between parasite and vertebrate host cells in a
process that involves a great variety of molecules present in
both cell starting the intracellular life cycle of Trypanosoma
cruzi. This cycle involves several steps like the formation of
an endocytic vacuole known as the parasitophorous vacuole,
adiﬀerentiationofthelongandthintrypomastigoteformsin
roundedwithashortﬂagellum,characteristicoftheamastig-
oteforms(alsoknownasintracellularspheromastigotes)and
lysis of the parasitophorous vacuole membrane by enzymes
secreted by the parasite [8] so that the amastigote forms
enter in direct contact with host cell organelles. Here, we will
review all basic steps involved in the process of interaction of
T. cruzi with cells both from the vertebrate and invertebrate
hosts. We will focus mainly on the basic biological processes
which take place in any kind of cell.
2. Adhesion of T. cruzi to Vertebrate Cells
The ﬁrst steps of the Trypanosoma cruzi—host cell interac-
tion process can be divided into three stages: adhesion and
recognition, signaling, and invasion. In studies of T. cruzi—
host cell interaction, we should consider: (i) the T. cruzi
strainusedinthestudies[10],(ii)whichdevelopmentalstage
is used [10], (iii) whether the trypomastigote form used is
slender or stout, and (iv) which host cell is used [11]. There-
fore, it is possible to anticipate that the mechanisms involved
on recognition, signaling, and invasion (or phagocytosis) are
complex.
The adhesion step involves the recognition of molecules
present on the surface of both parasite and host cells
(Figure 2). We cannot exclude the possibility that molecules
secreted by the parasite may also play some role in this
process, as clearly shown in members of the Apicomplexa
phylum. Adhesion and internalization are clearly diﬀerent
processes which can be separated. For example, when cells
are allowed to interact at 4◦C, only adhesion takes place
[12].Treatmentwithactinpolymerizationinhibitors,suchas
cytochalasins, also shows a clear picture of the adhesion step.
Adhesion is a process that depends on receptors restricted to
membrane domains. The adherence of the parasite to a host
cell does not mean that invasion will take place.
The mechanisms by which T. cruzi infective forms
gain access to the intracellular milieu are gradually being
disclosed. The involvement of parasite ligands and/or host
cell receptors has been extensively studied [13–15]. In the
next topics, we will review some T. cruzi and host cell
molecules involved in the recognition of both cells.
3. Recognition Process inthe VertebrateCell
3.1. Parasite Molecules. Diﬀerent strains of T. cruzi as
well as diﬀerent forms of the parasite (tissue culture-
derived trypomastigotes, metacyclic trypomastigotes and
amastigotes), express diﬀerent molecules on their surface.
These surface molecules interact with host components to
invade mammalian cells. First, we will comment on the
trypomastigote surface molecules and then those present on
amastigote.
In 1983, Nogueira [19] described, using macrophages as
thehostcell,theantiphagocyticeﬀectofagp90moleculethat
is present in the mammalian stages of T. cruzi. This molecule
seemed to have glycosidase activity and its antiphagocytic
activity was mediated by the removal of sugar residues nec-
essary for parasite internalization. The ability of metacyclic
trypomastigote gp90 to downregulate host cell invasion has
been associated to the lack of Ca2+ signal-inducing activity
by this molecule. Intracellular Ca2+ mobilization, both in
the target cell and the parasite, was required for T. cruzi
internalization [13, 20]. Binding of gp90 to mammalian
cells does not trigger these Ca2+ responses [21]. The gp90
molecule is easily digested by gastric juice (pepsin), thus
explaining the observation that when isolates rich in gp90
were accidentally ingested the parasite entry in host cells
and the infection was maintained [22]. Trypanosoma cruzi
molecules known as mucins are also involved in host cell
invasion. Mucins are the major T. cruzi surface glycoproteins
and their sugar residues interact with mammalian cells
[23, 24]. Many mucins have been implicated in host cell
infections [24–26]. Schenkman and colleagues [27]r e p o r t e d
that mucins can also act as ligands.
In 1986, an 85KDa glycoprotein was identiﬁed as a
ligand of ﬁbronectin in diﬀerent cell types like monocytes,
neutrophils and ﬁbroblasts [30, 31]. This glycoprotein is
known as Tc85. The Tc85 molecule is abundant in trypo-
mastigotes and is characterized as part of the gp85/trans-
sialidase family together with other proteins such as gp85,
gp82, TSA-1, and trans-sialidases. This superfamily shares
common motifs with bacterial neuraminidases; however, all
members of this superfamily contain a conserved sequence
(VTVXNVFLYNR)thatisabsentinbacterialneuraminidases
[32]. The members of this group are expressed on the
parasite’s cell surface and their concentration is stage-
speciﬁc[33].Tc85formsapopulationofheterogeneousGPI-
glycoproteins with similar molecular masses but diﬀerent
isoelectric points [34–37]. Using monoclonal antibodies that
recognize Tc85 glycoproteins, like H1A10, host cell invasion
was inhibited by 50%–96% [31, 34]. The Tc85 family is
capable of binding to diﬀerent host receptor molecules either
located on the cell surface, like host cell cytokeratin 18
[14], or belonging to components of extracellular matrix,
like ﬁbronectin [30] and laminin [38], since this family is
composed of multiadhesive glycoproteins.
Two groups of glycoproteins, gp82 and gp35/50, are also
involved in parasite invasion. Both proteins are expressed
on the surface of metacyclic trypomastigotes [39]. These
glycoproteins constitute the main surface molecules of the
metacyclic form in diﬀerent T. cruzi strains and appear
to be highly immunogenic, since mouse immunized with
heat-killed metacyclic trypomastigotes produce antibodies
which predominantly recognize these antigens and lyse the
metacyclic forms in a complement-dependent reaction [39].
Gp82 is present only in metacyclic trypomastigotes, since
antibodies against this protein did not produce any reaction
towards amastigotes, epimastigotes, or tissue culture-derived
trypomastigotes[40].Ruizandcolleagues[21]demonstrated4 International Journal of Cell Biology
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Figure 2: Schematic model summarizing the molecules involved on parasite-host cell interaction process and exposed on the surface of a
hypothetical host cell and in trypomastigotes of Trypanosoma cruzi.
that puriﬁed gp82 binds less eﬃciently to HeLa cells than
gp90 or gp35/50, but gp82 is capable of activating a Ca2+
signaling in this cell. In 1998, Favoreto and colleagues [41]
demonstrated that gp82 is the signaling receptor that medi-
ates protein tyrosine phosphorylation which is necessary for
hostcellinvasion.Also,phospholipaseCandIP3areinvolved
in this signaling cascade that is initiated with parasite cell
surface by gp82 and leads to Ca2+ mobilization required to
target cell invasion [10, 41]. Gp82 is a glycoprotein present,
mainly, in the G strain while gp35/50 is mostly concentrated
in the CL strain. Metacyclic trypomastigotes of the CL strain
trigger the Ca2+ signaling pathway in host cells following
parasite adhesion mediated by gp82 [21, 42, 43]. Gp35/50
molecules are not as eﬀective as gp82 in promoting invasion,
probably due to their poor Ca2+ signal-inducing activity.
These mucin-like gp35/50 molecules, abundant on the
surfaceandresistanttoproteasedigestion,areresponsiblefor
protecting the metacyclic trypomastigotes from destruction
during infection by the oral route [7].
Anothergroupofmoleculespresentonthesurfaceofcul-
ture trypomastigotes are the trans-sialidases. Trans-sialidase,
auniqueenzymeofT.cruzi,isasurface-boundproteinwhich
is shed by the parasite into the external milieu. This trans-
sialidase is a modiﬁed sialidase that,instead of releasingsialic
acid, can transfer it from sialoglycoconjugates in the host
to terminal β-galactoses in the parasite’s glycoconjugates,
which are unable to synthesize these molecules [44]. This
enzymatic activity is diﬀerent from the known eukaryotic
sialyltransferases present in the Golgi complex that exclu-
sively use CMP-sialic acid as the donor substrate. The
trans-sialidase gene family comprises at least 140 members,
which can be classiﬁed into three groups according to the
structure and function of the protein product [45]. Trans-
sialidases are expressed by trypomastigotes and are anchored
by glycosylphosphatidylinositol (GPI) to the parasite plasma
membrane. They have two main regions: an N-terminal
catalytic region and a C-terminal extension, which repeats
12 amino acids (SAPA repeats) in tandem. By using anti-
TS monoclonal antibodies, diﬀerent cell types, and parasite
isolates, Prioli and colleagues [46] demonstrated that the
transference of sialic acid residues from the host cell to
the parasite hinders T. cruzi infection. Subsequently, Pereira
and colleagues [47] using trypomastigotes expressing trans-
sialidases (TS+) and trypomastigotes that do not express
trans-sialidases (TS−) demonstrated that the TS+ popula-
tion was highly invasive, whereas TS− was extremely ineﬃ-
cient to infect nonphagocytic cells. Sialic acid is incorporated
by trans-sialidases mainly into mucins present in the plasmaInternational Journal of Cell Biology 5
membrane of trypomastigotes [27]. Sialylation process in T.
cruzi was shown to confer resistance to the human comple-
ment, which is a prerequisite for infection [48]. Although
TS and sialylated glycoconjugates apparently exhibit critical
functions for infection, persistence, and pathogenesis of
Chagas disease, the exact molecular mechanisms of their
function and the receptors for these sialylated structures on
the diﬀerent host cells are still unknown [49]. Jacobs and
colleagues [49] demonstrated that trypanosomal TS removes
sialic acid from the cell surface, thereby discharging Siglecs
(sialic acid-binding Ig-like lectins) present in diﬀerent cells
a n du s e db yd i ﬀerent pathogens sialylated.
Inactive trans-sialidase is a sialic acid-binding lectin that
costimulates host T cells through leucosialin (CD43) engage-
ment [50]. Analyzing inactive members of the trans-sialidase
family, Todeschini and colleagues [51] demonstrated that the
proteins can physically interact with sialic acid-containing
molecules on host cells and could play a role in host cell/T.
cruzi interaction.
Present in all strains of Trypanosoma cruzi, Gp83 is
a ligand employed by the parasite to attach and enter
phagocytic and nonphagocytic cells [53, 54] and it is
expressed only in infective trypomastigotes [55]. Another
molecule known as penetrin, a 60kDa protein that has an
aﬃnity to extracellular matrix elements, selectively binds
to heparin, heparan sulfate, and collagen and promotes
ﬁbroblast adhesion and penetration [56].
Some T. cruzi proteases have been implicated in host
cell infections like cruzipain, oligopeptidase B, and Tc80.
Cazzulo and colleagues [57] isolated and characterized a
lysosomal cysteine proteinase, from epimastigotes of T.
cruzi, named “cruzipain”. This enzyme is able to degrade
bovine serum albumin, hemoglobin, and azocasein at pH 5.0
[58]; contains amino acid sequences presenting considerable
homology with papain and cathepsin L [59]; and is a high-
mannose type of glycoprotein, as shown by binding to con-
canavalin A Sepharose, endo-AT-acetyl-glucosaminidase H
sensitivity, and determination of oligosaccharide chain com-
position [59, 60]. Souto-Padr´ on and colleagues [60]d e m o n -
strated that cysteine proteinase is located in endosomal-
lysosomal (reservosome) system of epimastigotes but is also
expressed on the surface of epimastigotes and amastigote-
trypomastigote transitional forms. It was also showed that
addition of antiproteinase antibodies to the interaction
medium signiﬁcantly inhibited the ingestion of parasites by
macrophages. This cysteine protease is secreted through the
ﬂagellar pocket of T. cruzi and has been described to cleave
hosthighmolecularweightkininogentogenerateshort-lived
kinins which bind to the bradykinin receptor to stimulate
IP3-mediated Ca2+ release [61, 62].
Oligopeptidase B, an 80KDa cytosolic serine endopep-
tidase, is secreted by trypomastigotes of T. cruzi [63, 64].
This soluble factor is generated by the action of an alkaline
peptidase on precursors present only in infective trypo-
mastigotes [64] and this peptidase is seemed to indirectly
induces [Ca2+]i-transients during T. cruzi invasion [64, 65].
Tc80 is a prolyl oligopeptidase, a member of the serine
protease family that hydrolyses human collagen types I and
IV at neutral pH and also ﬁbronectin which is important
for the parasite’s transit through the extracellular matrix [66,
67]. Grellier and colleagues [67] using selective inhibitors
for Tc80 showed that the parasite’s entry into the host cell
was blocked, indicating that this molecule could be used as a
possible good target for Chagas’ disease chemotherapy.
In the case of amastigote, surface components that are
involved in attachment and internalization in host cells
have not yet been well identiﬁed. Evidences indicate that
a carbohydrate epitope deﬁned by a monoclonal antibody
1D9, abundant in lineage 1 of T. cruzi [68, 69], could be
implicated in this process since Mab 1D9 speciﬁcally inhibits
parasite invasion [68]. Recently, da Silva and colleagues
[70] described a 21KDa ubiquitous protein secreted by
extracellular amastigotes. Pretreatment of host cells with
P21-His6 inhibited cell invasion by extracellular amastigotes.
On the other hand, when the protein was added to host cells
at the same time as amastigotes, an increase in cell invasion
was observed, suggesting that p21 might be involved in T.
cruzi cell invasion.
3.2. Host Cell Molecules. Since T. cruzi’s entry process is a
multifactorial process, many molecules that are present in
the membrane of the host cell, are potential partners for
recognition. These factors can vary depending on the cell
type involved. During initial studies, Kipnis and colleagues
[71] showed that macrophages pretreated with trypsin, anti-
macrophage serum or with the incubation of both parasites
and cytochalasin B had no eﬀect on parasite uptake. But
previous macrophage treatment with cytochalasin B blocked
parasite invasion. On the other hand, Henriquez et al. [72]
showed that host cells (like Vero and chick muscle cells)
pre-treated with concanavalin A, phytohemaglutinin, wheat
germ agglutinin, or ricin impaired trypomastigote invasion.
The authors also showed that trypsin and periodate treat-
ment also inhibited parasite infection, showing the partici-
pation of proteins and glycoproteins during the process.
The other Toll-like receptors which recognize T. cruzi
are Toll-like receptors 4 and Toll-like receptors 9. The GIPL
ceramide isolated from epimastigotes of T. cruzi is suggested
to interact with Toll-like receptor 4. Toll-like receptor 9 is
known to be activated by methylated CpG-rich DNA and T.
cruzi DNA in macrophages [88].
4. Morphology of the Adhesion and
InternalizationProcess
One class of receptors present in mammalian cells is rep-
resented by lectin-like molecules. Lectins are sugar-binding
proteinswhicharehighlyspeciﬁcfortheirsugarmoietiesand
are involved in attachment between pathogens and host cells
[73]. Galectin-3 [74], a β-galactosyl-binding lectin, is a type
of lectin involved in T. cruzi attachment has been suggested
to mediate parasite attachment and entry in dendritic cells
[75] and in smooth muscle cells [76]. Carbohydrate residues
present in the plasma membrane of mammalian cells can
function as receptors. Using electron spectroscopic imaging
(ESI) and lectins like WGA, RCA I, and ConA, Barbosa
and de Meirelles [77] detected galactosyl, mannosyl and6 International Journal of Cell Biology
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Figure 3: Immunoﬂuorescence microscopy colocalization (arrows) of phosphorylated proteins (b, g), detected using antiphosphotyrosine
antibody, actin ﬁlaments (c), detected using phalloidin, and PI3 kinase (f) detected using anti-PI3 Kinase antibody during penetration
of T. cruzi into macrophages. The overlay images (d, h) show the areas of colocalization demonstrating that phosphorilated proteins and
microﬁlaments participate in internalization of T. cruzi trypomastigotes by macrophages. Bars = 5μm( a f t e r[ 9]).
sialyl residues in regions of host-cell plasma membrane that
are internalized together with the parasite. Glycosylation
mutants of Chinese hamster cells (CHO) showed that
adhesion and invasion of T. cruzi was impaired in cells that
express very few sialic acid residues. If the deﬁcient cell line
was incubated in the presence of exogenous fetuin and T.
cruzi trans-sialidase, the infection process was similar to that
observed in parental cells [78].
Integrins, receptors that mediate attachment between
two cells or cell and extracellular matrix, are involved in
the invasion processes. Tc85, that is present at T. cruzi
membrane and has been associated with parasite invasion,
contains ﬁbronectin-like binding sequences [79]a n da
laminin-binding domain [78]. Besides functioning as a
cellular link to laminin or ﬁbronectin, integrins function as
receptors that can activate PI-3 kinase signaling pathways.
Tc85 could bind to cytokeratin 18, a cytoskeletal protein
that was suggested to function as a T. cruzi receptor [42].
H o w e v e r ,w h e nc y t o k e r a t i n1 8e x p r e s s i o nw a ss i l e n c e db y
RNAi, trypomastigote binding to host cells was not aﬀected,
although intracellular growth of amastigotes was impaired
[80].
Another molecule present on the host cell surface and
involvedintrypomastigotes’entryistheTGFreceptor.Signal
transduction through TGF-β receptors facilitates T. cruzi
entry into epithelial cells [15, 81]. However, the molecule
present in trypomastigotes that is capable of binding to the
TGF β receptor is not yet known. Scharfstein and Morrot
[15] proposed that infective stages of T. cruzi secrete a
TGFβ-like molecule or a factor capable of activating latent
host TGFβ. The exposure of phosphatidylserine on the
surface of Trypanosoma cruzi trypomastigotes [82] and its
deactivating eﬀect on macrophages by the induction of TGF
β suggests that phosphatidylserine is a possible activator of
TGF β [82].
The bradykinin receptors are another class of receptors
used by trypomastigotes to penetrate mammalian cells.
They are coupled to the heterotrimeric protein G and are
formed by two subtypes: the bradykinin 2 receptor, which
is constitutively expressed by cardiovascular cells, and the
bradykinin 1 receptor whose expression is upregulated in
injured tissues [62]. The use of chinese hamster ovary
(CHO) cells overexpressing bradikinin2 receptor showed
that trypomastigotes’ invasion is modulated by combinated
activities of kininogens, kininogenases, and kinin degrading
peptidases. Trough bradykinin 2 receptor, trypomastigotes
elicit vigorous intracellular free calcium transients.
Present in neuronal and dendritic cells, the nerve growth
factorreceptorTrkAleadstoT.cruziinvasionthroughtrypo-
mastigotetrans-sialidasebinding[83].Moreover,manytypes
of neurons and glial cells express a neurotrophic receptor
called TrkC (tyrosine kinase C). T. cruzi binds to TrkC to
maximize host-parasite equilibrium in the nervous system
and this interaction is mediated by trans-sialidase/parasite-
derived neurotrophic factor (PDNF), previously identiﬁed as
a TrkA ligand. Thus, TrkC is a new neurotrophic receptor
that T. cruzi engages to promote the survival of neuronal and
glial cells [83].
In 2001, Campos and colleagues [84] described that Try-
panosoma cruzi derived glycosylphpsphatidylinositol (GPI)
linked to mucin-like glycoproteins and glycoinositolphos-
phoslipids (GIPLs) were recognized by TLR2/CD14 of host
cells. Toll-like receptor activates nuclear factor κBa n d
interferon regulatory factor dependent pathway [85]. T.
cruzi-derived GPI anchors can also phosphorylates mitogen-
activated protein kinases (MAPKs) and IκBi nm a c r o p h a g e sInternational Journal of Cell Biology 7
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Figure 4: Imunoﬂuorescence microscopy localization of GM1 (a–d) and ﬂotillin 1 (e-f) during internalization of T. cruzi trypomastigotes
by macrophages suggests the participation of membrane microdomins in this process. (a–d) colocalization of GM1, using cholera toxin
subunit B (a) and an intracellular parasite ((c): arrow). (b) shows labeling of the nucleus and kinetoplast labeled with propidium iodide.
(c) corresponds to a DIC image; (d) is a merge image. (e-f): Colocalization of ﬂotillin1 (a), detected using a speciﬁc antibody, and
trypomastigotes ((b): arrows) bars – 5μm( a f t e r[ 16]).
[86]. Maganto-Garcia and colleagues [87] demonstrate that
Toll-like receptors 2 induces phagocytosis of trypomastigotes
by stimulating the activation of Rab5. Tissue-culture derived
trypomastigotes initiate an inﬂamation process after trigger-
ing Toll-like receptor-2 in macrophages [88].
Since Trypanosoma cruzi infects several cell types and
uses diﬀerent mechanisms to invade host cells, a wide type of
morphological events could be observed. Our group demon-
strated by ﬁeld emission scanning electron microscopy that
even after a short interaction time, all developmental stages
of T. cruzi are readily ingested by the macrophages. After 15
minutesofinteraction,avarietyofinteractiontypescouldbe
distinguished morphologically. In the case of trypomastigote
forms, most of them entered the macrophages with their
posterior region (65%). While amastigotes stages did not
show a preferential region of entrance epimastigotes, the
noninfective stage of T. cruzi, were internalized mainly via
the ﬂagellar region. The macrophages’ plasma membrane
are covers the parasite by forming a funnel-like structure
or a structure described as a coiled-coil phagosome [29].
The use of drugs which inhibits PI 3 Kinase (PI3K) activity
demonstrated that trypomastigotes entered mainly through
the posterior region, in drug-treated cells the trypomastig-
otes entered mainly through the anterior region. However, in
the case of epimastigotes, PI3K inhibitors did not interfere
with the entry pattern. Inhibition of PI3K inhibited the
complete sealing of surface projections that participate in
theendocyticprocess.TheseresultssuggestthatwhenPI3Kis
blocked,trypomastigotesuseanothertypeofligand,exposed
on their anterior region to initiate the invasion process [29].
5. Triggeringof the EndocyticActivity
Following binding and recognition of the parasite by the
host cell surface, a series of cell signaling processes take place
whichculminateintheinvasionofthehostcell.Theavailable
evidence indicates that the trypomastigote stage of T. cruzi
uses several mechanisms to signal and invade host cells.
One entry mechanism is phagocytosis/macropinocytosis,
where the cells emit pseudopods and there is participation
of actin ﬁlaments. In professional phagocytes (such as
macrophages) the activation of tyrosine kinase proteins was
observed, followed by the recruitment of PI-3 kinase and8 International Journal of Cell Biology
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Figure 5: Macrophages ﬁrst labeled with ferritin-ConA at 4◦C, incubated with T. cruzi at 4◦C, and then incubated for 30min at 37◦C, after
which the cultures were ﬁxed. The ferritin particles (arrows in (a) and (b)) associated with the membrane of vacuoles without parasites are
uniformlydistributed,showingapatchydistributioninthosevacuolesthatcontainparasites.(b)Highmagniﬁcationoftheareamarkedwith
an asterisk in (a), showing in detail the membranes of two diﬀerent vacuoles. hcn, host cell nucleus; p, parasite; and pvc, parasite-containing
vacuole. Bars = 1μm( a f t e r[ 17]).
actin ﬁlaments (this process has been associated with the
mechanism of phagocytosis) at the spot of entry of the
trypomastigote [9], showing that phagocytosis is the main
mechanism of T. cruzi entry in macrophages (Figure 3).
In another mechanism known as endocytosis, emission of
pseudopods does not take place, but present participation
of actin ﬁlaments. Trypomastigotes can also entry by invagi-
nation of the membrane, without participation of actin
ﬁlaments. This latter process has been regarded as an active
mechanism for the entry of the parasite with waste of
energy [89].
In the initial moments of the recognition between T.
cruzi and the host cell, a transient increase of cytoplas-
mic levels of calcium (in both parasite and host cell)
occurs [10, 90, 91]. If this transient increase in cytoplasm
calcium is blocked by treatment with thapsigargin, for
example, a reduction of parasite invasion was observed
[92]. Also, in nonprofessional phagocytic cells there is
a recruitment of lysosomes to the place of invasion of
the parasite, although this phenomenon represents about
20% of entering parasites (it occurs in about 20%). The
lysosome-dependent pathway is initiated by targeted Ca2+-
regulated exocytosis of lysosomes at the plasma mem-
brane. Another pathway used for parasite internalization
in nonphagocytic cells is the lysosome-independent path-
way. In this model, parasites enter cells through plasma
membrane invaginations that accumulate PIP3, the major
product of class I PI3K activation. As a result of this
mode of entry, around 50% of total internalized parasites
are contained in vacuoles enriched in plasma membrane
markers and about 20% are in early endosomes (EEA1
labeled) at 10min postinfection. In this case, the imma-
ture vacuole is enriched with lysosomes within 60 min
[93].
Transient increases of calcium in the cytoplasm of the
host cell, after the interaction with trypomastigotes of T.
cruzi, has been shown to cause a reorganization of the
actin cytoskeleton [92, 94]. Also, depolymerization of actin
ﬁlaments at the parasite site of entry may enhance parasite
invasion [95]. Several studies using host cells treated with
cytochalasins D or B (agents that depolymerize actin ﬁla-
ments) before the process of interaction with trypomastigote
forms showed controversial data: some authors say that the
treatment inhibits the entry of trypomastigotes [11, 96, 97],
others describe a sharp increase in entry [98], while others
[72] showed almost no eﬀect. However, when analyzing all
the data, we see that the time of treatment, interaction times
with trypomastigotes, the nature of host cells and the strains
of T. cruzi varied among the experiments. In addition, we
can not exclude the possibility that attached parasites were
considered as ingested.
The entry of the trypomastigotes activates signaling pro-
cesses in the host cell, leading to the invasion of the parasites.
In professional phagocytes the activation of tyrosine kinases,
recruitment of PI-3 kinase and actin at the parasite entry site
occur [29, 99]( Figure 3).
Activation of tyrosine kinases does not occur in non-
professional-phagocytic cells, as shown in studies where
inhibitors of these enzymes were used resulting in no
reduction of the invasion process. However, the activation
of PI-3 kinase occurs [28] and this activation seems to be
a regulator of the phagocytosis with the participation ofInternational Journal of Cell Biology 9
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Figure 6: (a, b) DTAF (sialic acid marker) labeled macrophages were incubated with trypomastigote forms of Trypanosoma cruzi for 1hr
at 37◦C. Observation by confocal laser scanning microscope (CLSM): DIC image (a) and corresponding ﬂuorescence (b) images. Observe
the labeling of the membrane lining the parasitophorous vacuole containing a trypomastigote form (arrow); (c, d) macrophages labeled
with PKH-26 (lipid marker) were allowed to interact with trypomastigote forms of T. cruzi for 1hr at 37◦C. Observation by CLSM: DIC
(c) and corresponding ﬂuorescence images. Observe labeling of the plasma membrane in the parasitophorous membrane containing a
trypomastigote form (arrow). Bar: 5μm( a f t e r[ 18]).
the host cell lysosomes [28], including the involvement of
tyrosine phosphatase in this process.
Host cell plasma membrane microdomains were also
shown to be involved in T. cruzi entry both in non-
phagocytic and phagocytic cells [16, 100]. Both groups
demonstrated that cholesterol, the major components of
membrane rafts and molecular markers of this domain like
ﬂotillin1 colocalized with trypomastigote and amastigote
entry sites, suggesting the participation of microdomains in
Trypanosoma cruzi invasion (Figure 4).
6. Parasitophorous Vacuole Assembly
After the recognition process between T. cruzi trypomastig-
ote and a host cell, the parasite may or may not invade
it. It was shown that sugar residues are important during
recognition and invasion. So, with the use of labeled
Concanavalin A (ﬂuorescein or ferritin labeled) it was
possible to show that Con A binding sites on the macrophage
surface were internalized together with the trypomastigote,
being observed associated with the parasitophorous vacuole
membrane [17]( Figure 5). Trypomastigote interaction with
cationized ferritin prelabeled macrophages (at 4◦C) showed
that the parasitophorous vacuole containing the parasite was
negative for cationized ferritin, although this marker can
be observed inside the cytoplasmic vesicles. Macrophages
incubated with cationized ferritin and horseradish peroxi-
dase at 37◦C, ingested both makers and concentrated them
in endocytic vacuoles. When these pre-labeled macrophages
were allowed to interact with trypomastigote stages, the
parasites were observed only in vacuoles labeled with
horseradishperoxidasebutnotwithcationizedferritin[101].
This observation suggests that the parasite may modulates
the parasitophorous vacuole membrane composition.
In 1987, De Carvalho and De Souza [102] showed
that opsonized trypomastigote and epimastigote stages
interacting with macrophages activate NAD(P)H oxidase
at the host cell membrane and that this enzyme is kept
activated inside the parasitophorous vacuole (PV). The
ﬁrst study describing the PV membrane composition used
a macrophage cell line and showed: (i) the presence of
Fc receptors [103] if trypomastigotes were opsonized with
anti T. cruzi antibodies; (ii) β 1 integrin and lysosomal
membrane glycoproteins (lgp); and (iii) the presence of
complement receptors (CR3), Fc receptors if epimastigotes10 International Journal of Cell Biology
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Figure 7: Trypomastigote vacuole is enriched in AKT-PH-GFP that binds to posphatidylinositolbiphosphate (PtdIns(3,4)P2)a n d
phosphatidylinositoltriphosphate (PtdIns(3,4,5)P3) that are products of PI3 Kinase (a–c) and also labeled to EEA1 and Rab 5 (d–f) and
Lamp-1 (g–i). (a–c) rapid accumulation of PtdIns(3,4,5)P3/PtdIns (3,4)P2a tt h eT. cruzi invasion site. Fluorescence images of (a) CHO cells
or (b) primary rat cardiomyocytes transiently expressing Akt-PH-GFP following incubation with infective T. cruzi trypomastigotes for 15
minutes. (c) T. cruzi invasion of CHO cells expressing Akt-PH-GFP
R25C which fails to bind to PtdIns (3,4,5)P3/PtdIns(3,4)P2. (d)–(f): early
association of T. cruzi with early endosomes is minimal and precedes lamp-1 acquisition. Immunoﬂuorescence staining of extracellular T.
cruzi (arrowheads) following infection of CHO cells transiently expressing Rab5-GFP (green). Host cell and parasite DNA is visualized with
DAPI (blue). (g–i) lamp-1 association with the Akt-PH-GFP-enriched T. cruzi vacuole occurs after parasite entry. L6E9 myoblasts expressing
Akt-PH-GFP (green) were infected with T. cruzi for 60 minutes and stained with anti-lamp-1 (red) and DAPI (blue). Bars = 5μm( a f t e r
[28]).
wereopsonizedwithanti-T.cruziantibodies;β1integrinand
lysosomalmembraneglycoproteins(lgp).Usingmusclecells,
Barbosa and de Meirelles [77] showed with Thi´ ery staining
that glycoconjugates were present in the parasitophorous
vacuole membrane. They also used ferritin labeled RCAI to
detect galactosyl residues and showed that in muscle cells
these residues accumulated in the parasite adhesion region
and these residues were internalized during parasite invasion
[77]. In 1994, Tardieux et al. [98] and Rodr´ ıguez et al. [104]
showed that lysosomes migrate early to the parasite entry site
in nonphagocytic host cells, contributing with membrane
during the PV formation. They pointed out, as requirements
for parasite entry, the participation of microtubules and
kinesin in the lysosomes migration from the perinuclear
region to the cell periphery [105]. The authors also show
that lysosome-membrane fusion is dependent on calcium
[105]. Ochatt et al. [106] showed, using macrophages that
GTP-regulated factors, but not calcium-regulated elements,
were involved in an early inhibition of phagosome-lysosome
fusion in T. cruzi infected macrophages. Carvalho et al. [18]
using ﬂuorescent markers showed that host cell membrane
lipids, proteins and sialoglycoconjugates contribute to the
membrane lining the PV, which contains epimastigotes and
trypomastigotes ingested by macrophages (Figure 6). Lyso-
somefusionattheparasiteentrysiteduringearlyinfectionof
macrophagesbytrypomastigoteshasnotbeenclearlyshown.
Using nonphagocytic GFP-Rab5 transfected cells and con-
focal microscopy, Wilkowsky et al. [107] demonstrated theInternational Journal of Cell Biology 11
presence of Rab5 in early PV containing T cruzi, indicating
that some PV fuse ﬁrst with endosome vacuoles. Woolsey
et al. [28], using shortly infected nonprofessional phagocytic
cells, showed that 50% or more of invading T. cruzi trypo-
mastigotes use host cell plasma membrane during the PV
formation. They suggested that this process was facilitated by
the depolymerization of host cell actin microﬁlaments. They
also showed that this vacuole is enriched in products from PI
3-kinase and negative for lysosomal markers; approximately
20% of T. cruzi containing vacuoles were positive to EEA1
and Rab 5 and approximately 20% of T cruzi containing
vacuoles were positive for Lamp-1 (Figure 7). Questioning
T cruzi early residence in a phagolysosome, Andrade and
Andrews [108], blocked T. cruzi lysosome mediated invasion
and showed that the parasites were not retained inside the
host cell. They concluded that the phagolysosome fusion
is essential for parasite retention inside host cells and
development.Concerningthelysosomefusionattheparasite
entry site, Tyler et al. [109] showed that the parasitophorous
vacuole containing T. cruzi acts as a secondary microtubule
organizingcenter.Morerecently,Romanoetal.[110]showed
thatthePVcontainingT.cruziisdecoratedbytheautophagic
protein LC3. This paper also pointed out some interesting
observations: (i) host cell starvation or pharmacological
induction of autophagy before the infection with T. cruzi
signiﬁcantly enhances the number of infected cells, while
inhibitors of this process inhibited parasite invasion; (ii)
the absence or reduction of two proteins required in the
initial step of autophagosome formation (Atg5 and Beclin
1) reduces both the parasite entry and Lamp-1 association
with the PV; and (iii) autolysosomes are recruited to the
parasite site of entry. Fernandes et al. [100] and Barrias et
al. [16] observed in the PV containing T. cruzi the presence
of GM1, ﬂotillin and caveolin 1 shortly after infection, thus
suggesting the presence of microdomains in the membrane
lining the T. cruzi PV. Dynamin is essential to vacuole
parasitophorous formation since the blockage of its GTPasic
activity by dynasore (a dynamin inhibitor) impairs the
parasite internalization [29]( Figure 8).
7. Lysisof the Parasitophorous
Vacuole (PV) Membrane
Trypomastigote stages of T. cruzi use diﬀerent recep-
tor0073/linkers to get into host cells. Regardless of the
mechanism used (either by fusion of lysosomes at the site
of entry, by participation of components of the plasma
membraneorbyinitialfusionwithendosomecompartments
at the site of invasion), the parasite will be located in a
vacuole. Studies show that some molecules are excluded
when the vacuole is being formed. Some authors refer to
the process of lysis of the PV membrane as an “escape” of
the parasite from the parasitophorous vacuole. We prefer to
characterize this process as a consequence of disintegration
of the parasitophorous vacuole membrane. More studies are
necessary to better characterize the mechanism involved in
this important step of the T. cruzi life cycle. In the PV,
trypomastigote forms release trans-sialidase/neuraminidase,
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Figure 8: Field emission scanning electron microscopy of the
interaction between peritoneal macrophages treated with dynasore
60μM (for 20 minutes) and allowed to interact with T. cruzi
trypomastigotes (a), epimastigotes (b), and amastigotes (c). All
parasiteevolutiveformswerepartiallyrecoveredbythemacrophage
plasmamembraneindicatingthattheblockageofGTPasicdynamin
activitydidnotimpairthepseudopodextension,impairingonlythe
complete vacuole formation. The interaction time was enough to
complete the parasite entry into control macrophages. Bars = 1μm
(after [29]).
that will remove sialic acid residues from the PV membrane
making it sensitive to the action of Tc-Tox (a peptide that
has homology with the factor 9 of the human complement)
[111]. At the acidic pH of PV, this molecule will begin
to destroy, maybe by pore formation, the PV membrane
[8, 112, 113]( Figure 9). We suppose that the formation
of these small pores, associated with the action of secreted
enzymes, like transialidase/neuraminidase, by the parasite,12 International Journal of Cell Biology
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Figure 9: Transmission electron microscopy (TEM) of thin sections of macrophages infected with trypomastigote forms of T. cruzi.
Micrographs taken at diﬀerent inclination angles of the section. Focal disruption of the membrane lining the vacuole is observed (arrows in
(a) and (b)) and especially in (c) and (d); K = kinetoplast, P = parasite. Bars = 1μm( a f t e r[ 52]).
will lead to the fragmentation of the PV membrane. Host cell
treatment with drugs that raise the intracellular pH delayed
the fragmentation of the PV membrane [114]. On the other
hand, observations using CHO cells that are deﬁcient in
sialylation showed that the absence of sialic acid makes the
PV membrane more sensitive to lysis [115]. The presence of
sialic acid residues seems to protect the lysosome membrane
from lysis.
The amastigote stage was also shown to be infective to
phagocytic [52, 116] and nonphagocytic cells, an important
process during the cycle in diﬀerent hosts [117]. Observing
blood smears of mice infected with T. cruzi,w ec o u l dd e t e c t
the presence of an amastigote (or amastigote-like form)
in these infected mice. Stecconi-Silva et al. [118] showed
that amastigote was recognized by monoclonal antibody
againstC9complementprotein,suggestingthatTcToxisalsoInternational Journal of Cell Biology 13
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Figure 10: Model of T. cruzi invasion. The model indicates three distinct mechanisms of T. cruzi entry into host cell. (a) the lysosome-
dependent pathway is initiated by targeted Ca2+-regulated exocytosis of lysosomes in the plasma membrane; (b) in the actin dependent
pathway trypomastigotes penetrate into a host cell through a plasma membrane expansion that culminates in assembly of a parasitophorous
vacuole.Eitherlearlyendosomesorlysosomescanfusewiththeparasitophorousvacuole;(c)inthelysosome-independentpathway,parasites
enter cells through plasma membrane invaginations that accumulate PIP3 (product of class I PI3K activation). Subsequently, internalized
parasites are contained in vacuoles formed from the plasma membrane and it maturates with the acquisition of early endosome markers
(rab5andEEA1)andsubsequentlywiththeacquisitionoflysosomemarkers.Lateron,thethetrypomastigoteformgraduallytransforminto
aamastigoteformwithsimultaneouslysisoftheparasitophorousvacuolemembrane.Then,amastigotesindirectcontactwiththecytoplasm
start to divide.
present and active in intracellular amastigotes. Amastigotes
may be able to use transialidase and TcTox to lysis the
parasitophorous vacuole membrane in a process faster than
occurs with trypomastigote forms, although Stecconi-Silva
et al. [118] showed negligible transialidase and hemolytic
activity (TcTox activity) by amastigote forms only 12hs
after incubation with red blood cells. They also showed
that raising the host cell cytoplasm pH using chloroquine,
the time metacyclic remains in the parasitophorous vacuole
increased two times, with no eﬀect on amastigote. The
kinetic of metacyclic trypomastigote and amastigote stages
escaping from vacuole after raising host cell cytoplasm were
not aﬀected.
The trypomastigotes which started a process of diﬀeren-
tiation into amastigotes, while they are still located inside
the PV during its membrane fragmentation was observed
by transmission electron microscopy around 2 hours after
infection [8]. In Figure 10, we have a scheme that sinthesized
themechanismsusedbytrypomastigotestostartaninfection
in a host cell.
8.Perspectives
Since the discovery of Trypanosoma cruzi and Chagas’
disease a century ago, many groups have concentrated their
eﬀorts on understanding the parasite’s cell biology and its
interaction with diﬀerent host cells, including the vector
cells. Although signiﬁcant progress has been achieved on the
identiﬁcation of surface parasite molecules involved in the
interaction process very little information is available on the
nature of the host cell ligands involved in such processes.
This is certainly an important area for future research. The
available information also points in the direction of the co-
existence of several processes of penetration of T. cruzi into
diﬀerent cells. It is not yet clear what leads the parasite
to select among these mechanisms. We also have to better
understand the biogenesis of the parasitophorous vacuole.
Is there a signaling dictated by the parasite that leads to the
parasitophorous vacuole disintegration? Are there molecules
from the host cell cytoplasm that cooperate with this
process? Can this process be inhibited, and what would the
consequence to the parasite inside this vacuole be? Besides
this, little is known about parasite diﬀerentiation in the
mammalianandintheinsectvector.Isnutrientprivationthe
only mechanism responsible for the diﬀerentiation process?
What triggers the rupture of the host cell and the release of
infective stages into the intercellular space? Several of these
questions will be the subject of further investigation in the
next few years.
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